Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Naunyn Schmiedebergs Arch Pharmacol ; 394(4): 619-629, 2021 04.
Article in English | MEDLINE | ID: mdl-33104849

ABSTRACT

Protein kinase C inhibitor tamoxifen reduces symptoms of acute mania in bipolar patients and mania-like behaviors in animals. Memory impairment and altered levels of glutamate and glutamate/glutamine ratio have been reported in mania. Tamoxifen suppresses glutamate release which plays an important role in memory. The present study evaluated whether tamoxifen's activity participates in its antimanic efficacy in repeated sleep deprivation mania model. Mice were divided into control and 24-h sleep-deprived groups and were treated with vehicle or 1 mg/kg tamoxifen twice daily for 8 days. Sleep deprivation was repeated three times at intervals of 2 days. Square crossing and rearing were recorded as measures of locomotor activity. Memory and risk taking behavior were evaluated using novel object recognition and staircase tests, respectively. Glutamate and glutamine levels were measured in the frontal cortex and hippocampus. Behavioral tests were conducted 24 h after the second or immediately after the third sleep deprivations. Sleep deprivation increased locomotor activity and risk taking. Glutamate and glutamine levels and glutamate/glutamine ratio in the frontal cortex and hippocampus were unaffected. Locomotor hyperactivity was prevented by tamoxifen treatment. No change in the recognition index suggested lack of memory impairment in the model. These findings confirm the relevance of repeated sleep deprivation as a mania model and tamoxifen as an antimanic agent. However, future research is needed to further address lack of memory impairment in the model and lack of glutamatergic influence on the model and antimanic effect of tamoxifen.


Subject(s)
Antipsychotic Agents/therapeutic use , Mania/drug therapy , Sleep Deprivation/drug therapy , Tamoxifen/therapeutic use , Animals , Antipsychotic Agents/pharmacology , Behavior, Animal/drug effects , Brain/drug effects , Brain/metabolism , Glutamic Acid/metabolism , Glutamine/metabolism , Locomotion/drug effects , Male , Mania/etiology , Mania/metabolism , Memory/drug effects , Mice, Inbred BALB C , Risk-Taking , Sleep Deprivation/complications , Sleep Deprivation/metabolism , Tamoxifen/pharmacology
2.
Basic Clin Pharmacol Toxicol ; 97(3): 179-84, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16128913

ABSTRACT

The effects of the superoxide anion generators, pyrogallol and hydroquinone on relaxations induced by electrical field stimulation (70 V, 0.7 msec., 0.5-8 Hz for 5 sec.) and exogenous nitric oxide donor sodium nitroprusside, were investigated in rat penile bulb precontracted with phenylephrine (10(-4) M). Pyrogallol (10(-4) M, 3 x 10(-4) M) and hydroquinone (3 x 10(-4) M) reduced the relaxations induced by sodium nitroprusside, but had no effect on relaxations elicited by nitrergic nerve stimulation. After treatment with diethyldithiocarbamate (3 x 10(-3) M), an inhibitor of Cu/Zn superoxide dismutase, both agents reduced the relaxations induced by electrical field stimulation. Superoxide dismutase, at 300 U/ml, significantly reversed the inhibitory action of pyrogallol and hydroquinone on responses to sodium nitroprusside. This concentration of superoxide dismutase failed to reverse the inhibitory action of pyrogallol on responses to electrical field stimulation observed in the presence of diethyldithiocarbamate, while at 600 U/ml it significantly prevented the reduction in relaxations. However, even at 600 U/ml, superoxide dismutase did not alter the decrease in responses to electrical field stimulation evoked by hydroquinone in tissues pretreated with diethyldithiocarbamate. These results suggest that the nitrergic transmitter in rat penile bulb is protected against superoxide anions by endogenous Cu/Zn superoxide dismutase in a manner similar to gastric fundus and anococcygeus muscles.


Subject(s)
Antioxidants/pharmacology , Autonomic Nervous System/drug effects , Hydroquinones/pharmacology , Muscle, Smooth/drug effects , Penis/drug effects , Pyrogallol/pharmacology , Superoxides/metabolism , Animals , Ditiocarb/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , In Vitro Techniques , Male , Muscle Relaxation/drug effects , Muscle, Smooth/innervation , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitroprusside/pharmacology , Penis/innervation , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/antagonists & inhibitors , Superoxide Dismutase/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...